Hemofiltration Replacement Fluid of Sodium Bicarbonate and Phosphate
Indications:
This product can be used as a replacement fluid for the treatment of acute kidney injury during continuous renal replacement therapy (CRRT). VELCADE is indicated for acute late treatment after initiation of renal replacement therapy when pH, potassium, and phosphate concentrations return to normal. VELCADE may also be used if other buffers are in use or during topical citrate anticoagulation therapy. In addition, this product can be used in patients with hypercalcemia.
Specifications
5000m
Packaging
Outer barrier bag, three-layer co-extrusion, double-chamber bag packaging system for infusion, 5000ml (250ml + 4750ml) per bag, 2 bags/box.
